EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis

Umut Rende iD, Anna Guller, Ewa M Goldys, Carol Pollock, Sonia Saad iD

The Journal of Physiology · 2023-07 · 601 (14) · 2801-2826

DOI: 10.1113/jp284289 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2023-06-08. Written by Umut Rende and 4 co-authors. Institution: School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia. Major MEDLINE topics: Kidney, Renal Insufficiency, Chronic. Cited 44 times so far (Crossref); 136 references. The full text is freely available (open access, CC BY 4.0). Funded by: NSW Health, NSW Health PhD Partnership Program Scholarship.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Renal fibrosis is the final common pathophysiological pathway in chronic kidney disease (CKD) regardless of the underlying cause of kidney injury. Tubulointerstitial fibrosis (TIF) is considered to be the key pathological predictor of CKD progression. Currently, the gold‐standard tool to identify TIF is kidney biopsy, an invasive method that carries risks. Non‐invasive diagnostics rely on an estimation of glomerular filtration rate and albuminuria to assess kidney function, but these fail to diagnose early CKD accurately or to predict progressive decline in kidney function. In this review, we summarize the current and emerging molecular biomarkers that have been studied in various clinical settings and in animal models of kidney disease and that are correlated with the degree of TIF. We examine the potential of these biomarkers to diagnose TIF non‐invasively and to predict disease progression. We also examine the potential of new technologies and non‐invasive diagnostic approaches in assessing TIF. Limitations of current and potential biomarkers are discussed and knowledge gaps identified. image

Subjects

MeSH terms (MEDLINE)

KidneyRenal Insufficiency, ChronicAnimalsPrognosisFibrosisBiomarkers

Author keywords

biomarkerschronic kidney diseasenon-invasive diagnosticsrenal fibrosistubulointerstitial fibrosis

Substances

Biomarkers

Authors and institutions

  • School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia.
  • Macquarie Medical School, Faculty of Medicine, Health & Human Sciences, Macquarie University, NSW, Australia.
  • Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.

ORCID profiles: Umut Rende, Sonia Saad

Funding

  • NSW Health
  • NSW Health PhD Partnership Program Scholarship

Cite

APA

Rende, U., Guller, A., Goldys, E. M., Pollock, C., & Saad, S. (2023). Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology, 601(14), 2801-2826. https://doi.org/10.1113/jp284289

Vancouver

Rende U, Guller A, Goldys EM, Pollock C, Saad S. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology. 2023;601(14):2801-2826. doi:10.1113/jp284289

BibTeX
@article{Rende2023,
  author = {Rende, Umut and Guller, Anna and Goldys, Ewa M and Pollock, Carol and Saad, Sonia},
  title = {Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis},
  journal = {The Journal of Physiology},
  year = {2023},
  volume = {601},
  number = {14},
  pages = {2801--2826},
  doi = {10.1113/jp284289}
}
Start for free →